Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials.
Ketamine is an NMDA receptor antagonist with a variety of uses, ranging from recreational drug to pediatric anesthetic and chronic pain reliever. Despite its value in the clinical setting, little is known about the immediate and long-lasting effects of repeated ketamine treatment. We assessed the effects of chronic administration of a subanesthetic dose of ketamine on contextual fear conditioning, detection of pitch deviants and auditory gating. After four, but not two, weeks of daily ketamine injections, mice exhibited decreased freezing in the fear conditioning paradigm. Gating of the P80 component of auditory evoked potentials was also significantly altered by treatment condition, as ketamine caused a significant decrease in S1 amplitude. Additionally, P20 latency was significantly increased as a result of ketamine treatment. Though no interactions were found involving test week, stimulus and treatment condition, these results suggest that repeated ketamine administration impairs fear memory and has lasting effects on encoding of sensory stimuli.
Amann
Laura C
LC
SMRI Laboratory for Experimental Therapeutics in Psychiatry, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Halene
Tobias B
TB
Ehrlichman
Richard S
RS
Luminais
Stephen N
SN
Ma
Nan
N
Abel
Ted
T
Siegel
Steven J
SJ
D000161:Acoustic Stimulation; D000704:Analysis of Variance; D000818:Animals; D001307:Auditory Perception / Q000187:drug effects* / Q000502:physiology; D003214:Conditioning, Classical / Q000187:drug effects*; D004567:Electrodes, Implanted; D004597:Electroshock; D005072:Evoked Potentials, Auditory / Q000187:drug effects*; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000494:pharmacology*; D005239:Fear; D046352:Freezing Reaction, Cataleptic / Q000187:drug effects; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D007649:Ketamine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010897:Pitch Discrimination / Q000187:drug effects / Q000502:physiology
D018691:Excitatory Amino Acid Antagonists; D007649:Ketamine